Skip to content
10-Q

Quarterly Report

Jazz Pharmaceuticals plc JAZZ

0001232524-25-000074

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 60.77M sh
Shares Diluted Q3 2025 · Sep 30, 2025 61.61M sh
Shares Diluted Q3 2025 · Sep 30, 2025 60.96M sh
Shares Diluted Q3 2025 · Sep 30, 2024 63.17M sh
Shares Diluted Q3 2025 · Sep 30, 2024 67.51M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $125.02M
Stock Repurchased Q3 2025 · Sep 30, 2024 $311.43M
Capex Q3 2025 · Sep 30, 2025 $42.02M
Capex Q3 2025 · Sep 30, 2024 $24.78M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $993.26M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $997.33M
Long Term Debt Q3 2025 · Sep 30, 2025 $4.33B
Long Term Debt Q3 2025 · Dec 31, 2024 $6.08B
Short Term Debt Q3 2025 · Sep 30, 2025 $1.03B
Short Term Debt Q3 2025 · Dec 31, 2024 $31M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.33B
Cash And Equivalents Q3 2025 · Dec 31, 2024 $2.41B
Stockholders Equity Q3 2025 · Sep 30, 2025 $3.96B
Stockholders Equity Q3 2025 · Jun 30, 2025 $3.71B
Stockholders Equity Q3 2025 · Mar 31, 2025 $4.17B
Stockholders Equity Q3 2025 · Dec 31, 2024 $4.09B
Stockholders Equity Q3 2025 · Sep 30, 2024 $4.17B
Stockholders Equity Q3 2025 · Jun 30, 2024 $3.76B
Stockholders Equity Q3 2025 · Mar 31, 2024 $3.7B
Stockholders Equity Q3 2025 · Dec 31, 2023 $3.74B
Current Liabilities Q3 2025 · Sep 30, 2025 $2.27B
Current Liabilities Q3 2025 · Dec 31, 2024 $1.04B
Current Assets Q3 2025 · Sep 30, 2025 $3.76B
Current Assets Q3 2025 · Dec 31, 2024 $4.63B
Total Assets Q3 2025 · Sep 30, 2025 $11.36B
Total Assets Q3 2025 · Dec 31, 2024 $12.01B
Eps Diluted Q3 2025 · Sep 30, 2025 $4.08
Eps Diluted Q3 2025 · Sep 30, 2025 −$9.18
Eps Diluted Q3 2025 · Sep 30, 2024 $3.42
Eps Diluted Q3 2025 · Sep 30, 2024 $5.63
Eps Basic Q3 2025 · Sep 30, 2025 $4.14
Eps Basic Q3 2025 · Sep 30, 2025 −$9.18
Eps Basic Q3 2025 · Sep 30, 2024 $3.50
Eps Basic Q3 2025 · Sep 30, 2024 $5.93
Sga Expense Q3 2025 · Sep 30, 2025 $530.65M
Sga Expense Q3 2025 · Sep 30, 2025 $1.4B
Sga Expense Q3 2025 · Sep 30, 2024 $325.77M
Sga Expense Q3 2025 · Sep 30, 2024 $1.02B
Net Income Q3 2025 · Sep 30, 2025 $251.41M
Net Income Q3 2025 · Sep 30, 2025 −$559.6M
Net Income Q3 2025 · Jun 30, 2025 −$718.47M
Net Income Q3 2025 · Mar 31, 2025 −$92.54M
Net Income Q3 2025 · Sep 30, 2024 $215.06M
Net Income Q3 2025 · Sep 30, 2024 $369.01M
Net Income Q3 2025 · Jun 30, 2024 $168.57M
Net Income Q3 2025 · Mar 31, 2024 −$14.62M
Operating Income Q3 2025 · Sep 30, 2025 $57.51M
Operating Income Q3 2025 · Sep 30, 2025 −$684.78M
Operating Income Q3 2025 · Sep 30, 2024 $260.21M
Operating Income Q3 2025 · Sep 30, 2024 $525.86M
Revenue Q3 2025 · Sep 30, 2025 $1.13B
Revenue Q3 2025 · Sep 30, 2025 $3.07B
Revenue Q3 2025 · Sep 30, 2024 $1.05B
Revenue Q3 2025 · Sep 30, 2024 $2.98B